CDC recommends 2nd bivalent booster for seniors, immunocompromised

The CDC backed changes to the COVID-19 vaccination schedule on April 19, simplifying recommendations and including a second bivalent booster authorized by the FDA April 18 for senior populations and people who are immunocompromised.

Advertisement

According to published guidelines, people 65 and older can receive the second bivalent booster four months after their last vaccine dose.

For people who are immunocompromised, the second bivalent booster can be received two months after receiving their last vaccine. 

Authorization of the monovalent vaccines from Moderna and Pfizer was rescinded by the FDA. This means anyone who is unvaccinated can now receive one dose of the bivalent vaccine.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.